Description: - 2000 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies.- The target pathways include PI3K/Akt/mTOR, EGFR, FGFR, Met, etc..- Some compounds are already approved or in clinical phase.- Detailed instructions, compound structures, target information, IC50 values, activity descriptions, etc.- Various detection techniques such as NMR, HPLC/LCMS to ensure correct structure and high purity of the product and reduce false positives.